S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
NASDAQ:EMBC

Embecta (EMBC) Stock Price, News & Analysis

$10.59
+0.34 (+3.32%)
(As of 04/15/2024 ET)
Today's Range
$9.93
$10.61
50-Day Range
$10.25
$17.76
52-Week Range
$9.93
$32.00
Volume
677,177 shs
Average Volume
363,000 shs
Market Capitalization
$609.77 million
P/E Ratio
11.15
Dividend Yield
5.67%
Price Target
$16.00

Embecta MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
51.1% Upside
$16.00 Price Target
Short Interest
Bearish
5.55% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.48mentions of Embecta in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$32,500 Bought Last Quarter
Proj. Earnings Growth
3.27%
From $2.14 to $2.21 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.00 out of 5 stars

Medical Sector

370th out of 929 stocks

Surgical & Medical Instruments Industry

44th out of 97 stocks

EMBC stock logo

About Embecta Stock (NASDAQ:EMBC)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

EMBC Stock Price History

EMBC Stock News Headlines

EMBC Apr 2024 10.000 put
EMBC Apr 2024 20.000 call
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15
Embecta Shareholders Approve Directors and Compensation Plans
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Embecta Shares Fall Despite Outlook Raise, Strong 1Q
Embecta Sinks As Outlook Comes In Below Consensus
Why Embecta Stock Is Tanking Today
Why Embecta Stock Is Tanking Today
Earnings Preview For Embecta
Embecta Corp's Dividend Analysis
See More Headlines
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2024
Ex-Dividend for 3/15 Dividend
2/27/2024
Dividend Payable
3/15/2024
Today
4/16/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:EMBC
Fax
N/A
Employees
2,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.00
High Stock Price Target
$16.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+51.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$70.40 million
Pretax Margin
5.69%

Debt

Sales & Book Value

Annual Sales
$1.12 billion
Cash Flow
$3.81 per share
Book Value
($14.34) per share

Miscellaneous

Free Float
57,418,000
Market Cap
$609.77 million
Optionable
Optionable
Beta
0.73
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Devdatt Kurdikar (Age 56)
    President, CEO & Director
    Comp: $2.2M
  • Mr. Jacob P. Elguicze (Age 51)
    Senior VP & CFO
    Comp: $1.05M
  • Mr. Brian R. Capone (Age 49)
    VP, Chief Accounting Officer & Corporate Controller
    Comp: $645.16k
  • Mr. Jeffrey Z. Mann (Age 52)
    Senior VP, General Counsel, Head of Business Development & Corporate Secretary
    Comp: $959.45k
  • Mr. Shaun Curtis (Age 55)
    Senior Vice President of Global Manufacturing & Supply Chain
    Comp: $915.67k
  • Ms. Colleen Riley (Age 60)
    Senior VP & Chief Technology Officer
  • Mr. Pravesh Khandelwal
    VP & Head of Investor Relations
  • Ms. Ginny Blocki
    Senior Vice President of Global Marketing & Product Management
  • Ms. Jean M. Casner (Age 66)
    Senior VP & Chief Human Resources Officer
  • Mr. Tom Blount (Age 50)
    Senior VP & President of North America

EMBC Stock Analysis - Frequently Asked Questions

Should I buy or sell Embecta stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Embecta in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" EMBC shares.
View EMBC analyst ratings
or view top-rated stocks.

What is Embecta's stock price target for 2024?

2 Wall Street analysts have issued 1 year price objectives for Embecta's stock. Their EMBC share price targets range from $16.00 to $16.00. On average, they anticipate the company's stock price to reach $16.00 in the next year. This suggests a possible upside of 51.1% from the stock's current price.
View analysts price targets for EMBC
or view top-rated stocks among Wall Street analysts.

How have EMBC shares performed in 2024?

Embecta's stock was trading at $18.93 at the start of the year. Since then, EMBC stock has decreased by 44.1% and is now trading at $10.59.
View the best growth stocks for 2024 here
.

When is Embecta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our EMBC earnings forecast
.

How were Embecta's earnings last quarter?

Embecta Corp. (NASDAQ:EMBC) released its earnings results on Friday, February, 9th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.15. The company had revenue of $277.30 million for the quarter, compared to analysts' expectations of $264.92 million. Embecta had a negative trailing twelve-month return on equity of 18.66% and a net margin of 4.93%. The firm's quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.

How often does Embecta pay dividends? What is the dividend yield for Embecta?

Embecta announced a quarterly dividend on Friday, February 9th. Shareholders of record on Wednesday, February 28th will be paid a dividend of $0.15 per share on Friday, March 15th. This represents a $0.60 annualized dividend and a yield of 5.67%. The ex-dividend date is Tuesday, February 27th.
Read our dividend analysis for EMBC
.

Is Embecta a good dividend stock?

Embecta (NASDAQ:EMBC) pays an annual dividend of $0.60 per share and currently has a dividend yield of 5.85%. EMBC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 63.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EMBC will have a dividend payout ratio of 27.15% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EMBC.

What ETFs hold Embecta's stock?

ETFs with the largest weight of Embecta (NASDAQ:EMBC) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD), Small Cap US Equity Select ETF (RNSC) and Syntax Stratified SmallCap ETF (SSLY).Simplify Health Care ETF (PINK).

What guidance has Embecta issued on next quarter's earnings?

Embecta updated its FY 2024 earnings guidance on Friday, February, 9th. The company provided EPS guidance of 1.950-2.150 for the period, compared to the consensus estimate of 2.000. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Who are Embecta's major shareholders?

Embecta's stock is owned by a variety of institutional and retail investors. Top institutional investors include Cardinal Capital Management (0.02%). Insiders that own company stock include David F Melcher, Devdatt Kurdikar, Jacob Elguicze and Jeffrey Z Mann.
View institutional ownership trends
.

How do I buy shares of Embecta?

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EMBC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners